Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Common Equity: 2009-2011

Historic Common Equity for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to $297.6 million.

  • Lexicon Pharmaceuticals' Common Equity rose 49.14% to $252.8 million in Q3 2012 from the same period last year, while for Sep 2012 it was $252.8 million, marking a year-over-year increase of 49.14%. This contributed to the annual value of $297.6 million for FY2011, which is 20.46% up from last year.
  • Latest data reveals that Lexicon Pharmaceuticals reported Common Equity of $297.6 million as of FY2011, which was up 20.46% from $247.0 million recorded in FY2010.
  • Lexicon Pharmaceuticals' 5-year Common Equity high stood at $297.6 million for FY2011, and its period low was $163.5 million during FY2009.
  • Moreover, its 3-year median value for Common Equity was $247.0 million (2010), whereas its average is $236.0 million.
  • Data for Lexicon Pharmaceuticals' Common Equity shows a peak YoY surged of 51.09% (in 2010) over the last 5 years.
  • Lexicon Pharmaceuticals' Common Equity (Yearly) stood at $163.5 million in 2009, then soared by 51.09% to $247.0 million in 2010, then climbed by 20.46% to $297.6 million in 2011.